Biotechnology(BK4139),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

BK4139 Biotechnology

Not Yet Opened 10-21 16:00:00 EDT

87.85

-0.31

-0.35%

High88.68	Low87.54	Vol629.02M
Open88.16	D1 Closing88.16	Amplitude1.29%
Mkt Cap0.00	Tradable Cap0.00	Total Shares0.00
T/O20.71B	T/O Rate--	Tradable Shares0.00
P/B11.572431	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"BK4139","market":"US","secType":"PLATE","nameCN":"Biotechnology","latestPrice":87.84525,"timestamp":1792612799999,"preClose":88.15757,"halted":0,"volume":629016841,"delay":0,"changeRate":-0.003543,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Not Yet Opened","change":-0.312317,"latestTime":"10-21 16:00:00 EDT","open":88.157684,"high":88.67597,"low":87.542206,"amount":20709632910.079,"amplitude":0.012861,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1792675800000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":11.572431,"peRate":-1.881602,"turnoverRate":0.017818,"increases":224,"decrements":273,"flats":16,"marketCap":2224747028619,"floatMarketCap":2048662981015.2188},"requestUrl":"/m/hq/s/BK4139/tweets","defaultTab":"tweets","newsList":[{"id":"1110712386","title":"Hong Kong Stock Connect Innovative Drug Sector Plunges Sharply as Index Drops Over 4.6%, Zai Lab and Akeso Suffer Major Losses","url":"https://stock-news.laohu8.com/highlight/detail?id=1110712386","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1110712386?lang=en_us&edition=fundamental","pubTime":"2026-10-22 11:11","pubTimestamp":1792638672,"startTime":"0","endTime":"0","summary":"The recovery in Hong Kong Stock Connect innovative drug stocks came to an abrupt halt on October 22, with the sector taking a sharp turn for the worse. The underlying index of the HUABAO HANG SENG...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0348766576.USD","LU0417516571.SGD","520880","LU1720050803.USD","LU0348827113.USD","LU0417516738.SGD","LU2778985437.USD","IE00BPRC5H50.USD","LU0348767384.USD","IBBQ","09926","LU0540923850.HKD","LU0417516902.SGD","LU1794554557.SGD","BK4531","BK1588","BK4526","ZLAB","LU2399975544.HKD","LNGR","IE00B543WZ88.USD","BK4548","LU0348735423.USD","LU0348783233.USD","LU2488822045.USD","LU0348825331.USD","LU0561508036.HKD","BK1574","BK1161","06978","FLHK","LU0348784397.USD","09688","KURE","MEDX","BK4139","BK4588","BK4585","LU0634319403.HKD","LU1961090484.USD","IE00B5MMRT66.SGD","159992","LU2476274308.USD","LU2476274720.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677987970","title":"Amplia Therapeutics Secures A$4.78m R&D Tax Rebate to Advance Pancreatic Cancer Trials","url":"https://stock-news.laohu8.com/highlight/detail?id=2677987970","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677987970?lang=en_us&edition=fundamental","pubTime":"2026-10-22 10:57","pubTimestamp":1792637864,"startTime":"0","endTime":"0","summary":"Amplia Therapeutics ( ($AU:ATX) ) has shared an update. Amplia Therapeutics has received an A$4.78 million refundable Research and Development Tax ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/amplia-therapeutics-secures-a4-78m-rd-tax-rebate-to-advance-pancreatic-cancer-trials?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/amplia-therapeutics-secures-a4-78m-rd-tax-rebate-to-advance-pancreatic-cancer-trials?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","LENZ","BK4539","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677982409","title":"Arcus Biosciences Prices $250 Million Share Offering at $17.50 Per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2677982409","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677982409?lang=en_us&edition=fundamental","pubTime":"2026-10-22 10:53","pubTimestamp":1792637601,"startTime":"0","endTime":"0","summary":"Arcus Biosciences Prices $250 Million Share Offering at $17.50 per ShareArcus Biosciences priced an underwritten public offering of 14,285,715 common shares at $17.50 per share.Expected gross proceeds","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261022:nNDLk6DNt:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RCUS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677982471","title":"Arcus Biosciences Announces Pricing of $250 Million Public Offering of Common Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2677982471","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677982471?lang=en_us&edition=fundamental","pubTime":"2026-10-22 10:53","pubTimestamp":1792637580,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261022:nTUA5735PN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","RCUS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677474982","title":"Arcus Biosciences - Prices Public Offering of 14,285,715 Shares at $17.5 Per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2677474982","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677474982?lang=en_us&edition=fundamental","pubTime":"2026-10-22 10:53","pubTimestamp":1792637580,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261022:nTUA5735PN:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RCUS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677621984","title":"Bulletin Resources Sets November Date for Perth Annual General Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2677621984","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677621984?lang=en_us&edition=fundamental","pubTime":"2026-10-22 09:48","pubTimestamp":1792633693,"startTime":"0","endTime":"0","summary":"Bulletin Resources Limited ( ($AU:BNR) ) has issued an announcement. Bulletin Resources Limited has called its Annual General Meeting for 9.00 a.m....","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/bulletin-resources-sets-november-date-for-perth-annual-general-meeting?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/bulletin-resources-sets-november-date-for-perth-annual-general-meeting?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BNR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677883139","title":"Vanda Pharmaceuticals Inc. Published an Update to Their Financial Calendar","url":"https://stock-news.laohu8.com/highlight/detail?id=2677883139","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677883139?lang=en_us&edition=fundamental","pubTime":"2026-10-22 05:41","pubTimestamp":1792618870,"startTime":"0","endTime":"0","summary":"Vanda Pharmaceuticals Inc. published an update to their financial calendarVanda Pharmaceuticals will release third-quarter 2026 financial results on October 28, 2026, following the market close.Manage","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261021:nNDL1YhbcV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","VNDA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677988841","title":"Crispr Therapeutics Files Initial Beneficial Ownership Statement for CFO Andrew Jacob Silver","url":"https://stock-news.laohu8.com/highlight/detail?id=2677988841","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677988841?lang=en_us&edition=fundamental","pubTime":"2026-10-22 05:36","pubTimestamp":1792618595,"startTime":"0","endTime":"0","summary":"CRISPR Therapeutics Files Initial Beneficial Ownership Statement for CFO Andrew Jacob SilverCRISPR Therapeutics Chief Financial Officer Andrew Jacob Silver filed an initial statement of beneficial own","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261021:nNDL4fVlsq:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRSP","LU1861558580.USD","BK4556","BK4585","LU1861559042.SGD","BK4139","ARKG","BK4588","BK4611"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677600004","title":"Disc Medicine Director Kevin Bitterman Reports $3.35 Million Common Share Disposal","url":"https://stock-news.laohu8.com/highlight/detail?id=2677600004","media":"Reuters","labels":["insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677600004?lang=en_us&edition=fundamental","pubTime":"2026-10-22 05:34","pubTimestamp":1792618470,"startTime":"0","endTime":"0","summary":"Disc Medicine Director Kevin Bitterman Reports $3.35 Million Common Share DisposalDisc Medicine director Kevin Bitterman reported sales of 41,825 common shares held indirectly from Oct. 19-21, 2026.Re","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261021:nNDL3JFFd3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Disc Medicine Director Kevin Bitterman Reports $3.35 Million Common Share Disposal","news_tag":"insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LU0053671581.USD","IRON"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677060010","title":"Oric Pharmaceuticals CFO Dominic Piscitelli Reports Sale of $189,390.60 in Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2677060010","media":"Reuters","labels":["insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677060010?lang=en_us&edition=fundamental","pubTime":"2026-10-22 05:17","pubTimestamp":1792617479,"startTime":"0","endTime":"0","summary":"Oric Pharmaceuticals CFO Dominic Piscitelli reports sale of $189,390.60 in common sharesOric Pharmaceuticals Chief Financial Officer Dominic Piscitelli sold 14,000 common shares on Oct. 20, 2026, at $","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261021:nNDL6msTJQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Oric Pharmaceuticals CFO Dominic Piscitelli Reports Sale of $189,390.60 in Common Shares","news_tag":"insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ORIC","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677600102","title":"Capstone Holding Sets 1-for-30 Reverse Stock Split Effective October 19","url":"https://stock-news.laohu8.com/highlight/detail?id=2677600102","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677600102?lang=en_us&edition=fundamental","pubTime":"2026-10-22 05:17","pubTimestamp":1792617437,"startTime":"0","endTime":"0","summary":"Capstone Holding Sets 1-for-30 Reverse Stock Split Effective October 19Capstone Holding will implement a 1-for-30 reverse stock split at the opening of trading on October 19, 2026.Outstanding common s","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261021:nNDL7LMHM6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CAPS","BK4139","BK4104"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677600954","title":"Palisade Bio Files Initial Beneficial Ownership Statement for General Counsel and Corporate Secretary Julien E. Capers","url":"https://stock-news.laohu8.com/highlight/detail?id=2677600954","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677600954?lang=en_us&edition=fundamental","pubTime":"2026-10-22 05:09","pubTimestamp":1792616941,"startTime":"0","endTime":"0","summary":"Palisade Bio Files Initial Beneficial Ownership Statement for General Counsel and Corporate Secretary Julien E. CapersPalisade Bio General Counsel and Corporate Secretary Julien E. Capers filed an ini","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261021:nNDL2059nf:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4007","PALI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677600549","title":"7 Healthcare Stocks That Stand Out as Investors Pay up for the Sector","url":"https://stock-news.laohu8.com/highlight/detail?id=2677600549","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677600549?lang=en_us&edition=fundamental","pubTime":"2026-10-22 04:59","pubTimestamp":1792616340,"startTime":"0","endTime":"0","summary":"Investors have pushed the healthcare sector to a record high, and some favored stocks have high projected revenue growth rates through 2028The S&P 500 healthcare sector hit a high this week, as invest","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LFSC","LU0354030438.USD","LU2750360997.AUD","LU1712237335.SGD","BIB","SG9999015952.SGD","IYH","LU2456880835.USD","SG9999014575.USD","HRTS","LU1291159041.SGD","LU2168564495.EUR","LU1023059063.AUD","LU2023250330.USD","BK4196","LU0122379950.USD","LU1699723380.USD","LU1064131342.USD","GB00B4LPDJ14.GBP","LU1061106388.HKD","LU1974910355.USD","IE00BJJMRZ35.SGD","SG9999013999.USD","SG9999014898.SGD","WDNA","LU2210150020.SGD","IBBQ","MHIP","SG9999015945.SGD","IE00BSNM7G36.USD","BMED","LU0096362180.USD","LU1674673691.USD","LU2756315318.SGD","BK4533","LU0690374615.EUR","LU0234570918.USD","LU1868836757.USD","LU1868837300.USD","LU2237443382.USD","LU0417517546.SGD","LU1162221912.USD","MRK","LU0109391861.USD","LU2028103732.USD","LU0098860793.USD","SG9999015341.SGD","LU0225283273.USD","LU2361044949.HKD","LU2404859741.USD","LU2265009873.SGD","LU2720916845.USD","IE00B2B36J28.USD","LU2065171402.SGD","LU0861579265.USD","LU1032466523.USD","LU1791710582.SGD","LU2552382058.USD","SG9999001176.USD","LU1929549753.HKD","LU0690374961.EUR","LU2417539215.USD","IE00BWXC8680.SGD","LU1037948541.HKD","LU2404859667.USD","IE00BQXX3D17.EUR","LU2357305700.SGD","LU1941712264.USD","LU0114720955.EUR","PJP","LU0234572021.USD","LU2112291526.USD","LU0823416689.USD","LU2552382215.SGD","OZEM","IE00BFXG0V08.USD","FMED","LU2468319806.SGD","IE00BKPKM429.USD","SG9999001440.SGD","LU2108987350.USD","LU0210536198.USD","LU0345770308.USD","IE00BJLML261.HKD","LU0187121727.USD","CURE","LU1934455863.HKD","LU2065170008.USD","LU2750360641.GBP","SG9999014559.SGD","LLII","LU1366333091.USD","LU0689472784.USD","IE00BZ9MQY76.HKD","LU1979441026.SGD","LU1803068623.USD","LU2023251221.USD","LU1868836591.USD","IE00BFSS7M15.SGD","LU1057294990.SGD","BK4581","IE00BK4W5L77.USD","LABU","LU2491050154.USD","LU0965509010.AUD","IE00B894F039.SGD","THNR","LU0965508806.USD","LU2125910179.SGD","LU1917777945.USD","LU2552382132.HKD","MEDI","LU0265550359.USD","LU0985320562.USD","LU1623119135.USD","BK4501","LU2433249047.HKD","LU2462157665.USD","LU2237443978.SGD","MEDX","LU0456855351.SGD","SG9999002232.USD","SG9999015358.SGD","DXCM","LU0124676726.USD","LU0683600562.USD","BK4082","LU0251131958.USD","IE0034235188.USD","LU0106261372.USD","GNOM","IE00BQXX3C00.GBP","LU2211815571.USD","LU0471298694.HKD","SGXZ57979304.SGD","PPH","LU1069347547.HKD","LU1951200564.SGD","LU2125910336.SGD","SGXZ31699556.SGD","XBI","LU0107464264.USD","IE00B19Z3581.USD","LU1923622291.USD","LU2471134523.USD","LU0354030511.USD","IE00B5TLWC47.USD","LLY","LU1868837136.USD","LU2461242641.AUD","LU0289739699.SGD","LU0728928796.USD","IE0004445015.USD","LU1116320737.USD","SGXZ51526630.SGD","LU0198837287.USD","LU2168564065.EUR","LU1066051811.HKD","IHE","DHR","IE00BKVL7J92.USD","LU1791710400.SGD","ILDR","LU0342679015.USD","LU0097036916.USD","LU0323591593.USD","IE00B19Z8W00.USD","LU0708995401.HKD","IE00BLSP4239.USD","LU0640476718.USD","LU2237443549.SGD","LU0130517989.USD","LU1035775433.USD","LU0174119429.USD","LU1074936037.SGD","LU1267930573.SGD","BBH","LU2764262908.HKD","BK4568","LU0289960550.SGD","IE00B19Z9505.USD","SG9999002224.SGD","SGXZ81514606.USD","AGNG","TRUH","LU2125909593.SGD","SG9999018865.SGD","BK4599","LU0672654240.SGD","LU2602419157.SGD","LU0289961442.SGD","IE00BJJMRX11.SGD","HELX","LU0256863902.USD","LU1815333072.USD","LU2462591350.SGD","XLV","LU0345770993.USD","MRNY","IE0002141913.USD","IE00BZ1G4Q59.USD","IE00BMPRXR70.SGD","LU0390134368.USD","LU1551013342.USD","IE0002270589.USD","LU2236285917.USD","LU2362541273.HKD","ISRG","LU1691799644.USD","IE00BLSP4452.SGD","LU0069063385.USD","LU1989764664.SGD","BK4167","BK4504","LU1633808545.USD","LU2491050071.SGD","LU1066051225.USD","IE00BMPRXN33.USD","LU0942090050.USD","BK4532","BK4566","LU1670627923.USD","SG9999001176.SGD","LU1145028129.USD","LU0203347892.USD","LU1941712348.USD","LU2360032135.SGD","VEEV","LU0957791311.USD","LU1035773651.USD","LU2125909916.SGD","LU1066051498.USD","BK4559","LU1923622614.USD","LU0203202063.USD","LU1323610961.USD","PBE","LU1989772840.SGD","BK4613","SGXZ99366536.SGD","SG9999017495.SGD","LU2543165471.USD","BK4548","LU2089984988.USD","LU1988902786.USD","LU0528227936.USD","LU2168563687.JPY","LLYZ","LU1629891620.HKD","IE00B19Z9P08.USD","LU1983299246.USD","LU2168564222.USD","LU2089284900.SGD","BK4007","LU0820561818.USD","LU1119994496.HKD","LU0466842654.USD","BK4588","LU2087625088.SGD","BK4567","LU2237443465.HKD","LU2237443622.USD","LU2023250843.SGD","LU0096364046.USD","LU0820561909.HKD","LU2764263203.CNY","LU0385154629.USD","LU2065169927.USD","LU0882574055.USD","LU2271345857.HKD","BLLN","LU1236620750.USD","LU2023250504.SGD","GH","LU0208291251.USD","LU0708994859.HKD","BK4528","LU1548497426.USD","LU2125909247.SGD","LU2355687059.USD","LU2756315664.SGD","LU2362541513.USD","LU1951198990.SGD","LU0203345920.USD","LU1854104046.USD","PTH","PAWZ","SG9999015986.USD","LU2211814178.USD","LU1989771016.USD","ISUL","IE00BJJMRY28.SGD","LU1670628061.USD","LU0787776722.HKD","LU2324357040.USD","LU1814569148.SGD","CANC","LU1084165304.USD","IE00B1XK9C88.USD","LU2041044095.USD","IE00B19Z9Z06.USD","LU0353189763.USD","LU1201861249.SGD","LU0157215616.USD","LU0170899867.USD","LU1934455277.USD","LU0057025933.USD","LU2168564149.EUR","LU0006306889.USD","VRTX","LU0266013472.USD","SG9999018857.SGD","LU1934455194.USD","IE00B7KXQ091.USD","BK4535","LU0472753341.HKD","LU1069344957.HKD","LU1430594728.SGD","LU2896262040.SGD","IE00BBT3K403.USD","LU0859254822.USD","LU0823434740.USD","LU0072461881.USD","SG9999004303.SGD","LU1778281490.HKD","LGHT","LU1366192091.USD","SG9999014880.SGD","LU0868494708.USD","LU0980610538.SGD","TBXU","SG9999014914.USD","LU0689626769.HKD","IE00B19Z8X17.USD","LU0964807845.USD","LU2065171311.SGD","LU2125154778.USD","GDOC","BK4516","LU0011850046.USD","JDOC","LU0251142724.SGD","LU0320765489.SGD","LU0162691827.USD","LU1280957306.USD","LU2471134879.HKD","LU1720051017.SGD","LU2211817866.USD","LU1923621640.USD","BK4551","LU2237438978.USD","IE00BQXX3F31.USD","LU2244417387.USD","MRNX","LU0648001328.SGD","SG9999015978.USD","LU1804176565.USD","IE00B1BXHZ80.USD","LU0882574139.USD","LU0211331839.USD","LU1116320901.HKD","IDNA","IE00BYQQ9H92.USD","SG9999014567.USD","LU1236620834.HKD","LU1674673428.USD","GB00B4QBRK32.GBP","FTXH","LU1261432733.SGD","RXL","LU2095319765.USD","LU0203201768.USD","LU2746668974.SGD","LU0742534661.SGD","LU0175139822.USD","LLYX","LU2746668461.USD","LU0820562030.AUD","LU0868494617.USD","LU0128525929.USD","LU0557290698.USD","LU2111349929.HKD","LU2360108059.USD","LU2491049909.HKD","LU1551013425.SGD","LU2106854487.HKD","LU1093756325.SGD","LU1571399168.USD","LU0079474960.USD","LU0061475181.USD","LU0070302665.USD","IE00BFSS8Q28.SGD","BK4121","IE0005OL40V9.USD","LU0316494557.USD","LU0109394709.USD","LU2092937221.SGD","IE00B4JS1V06.HKD","IHI","SGXZ23171101.USD","IE00BN8TJ469.HKD","IE00B775H168.HKD","IE0009355771.USD","LU1037948897.HKD","IE00BN29S564.USD","TMED","LU0353189680.USD","LU0310800379.SGD","LU0965509101.SGD","IE000M9KFDE8.USD","GRAL","LU1854103824.USD","IE00BJT1NW94.SGD","LU2361045086.USD","LU2298321311.HKD","LU1868836914.USD","LU0158827781.USD","LU1989764748.USD","SG9999014906.USD","EKG","GNMX","HEAL","PODD","IE00BK4W5M84.HKD","LU0965509283.SGD","LU2210149790.SGD","LU0320765992.SGD","LU2361044865.SGD","LU1127390331.HKD","LU0058720904.USD","LU1093756168.USD","LU2471134796.USD","LU0029864427.USD","LU2213496289.HKD","LU1720051108.HKD","FHLC","LU0289739343.SGD","LU0432979614.USD","LU0061474960.USD","LU0133085943.USD","LU1066053197.SGD","IBB","IE0004445239.USD","IE00BFTCPJ56.SGD","LU1989772923.USD","LU0238689110.USD","LU2237443895.HKD","LU0048573561.USD","LU0786609619.USD","LU2362540622.SGD","LU0256863811.USD","BK4585","LU0477156953.USD","LU0320765646.SGD","IE00BKDWB100.SGD","LU2471134952.CNY","LU2764263039.SGD","LU0511384066.AUD","LU0094547139.USD","LU1153585028.USD","LU1267930730.SGD","LU1585245621.USD","ELIL","LU0943347566.SGD","MRNA","LU2125154935.USD","LU0823434583.USD","LU2089283258.USD","LU1923623000.USD","LU1232071149.USD","LU0471298777.SGD","LU2063271972.USD","IE0001KFT4U8.USD","LU2360106947.USD","IE00B19Z3B42.SGD","LU2125909759.SGD","BK4534","LU0265550946.USD","LU0312595415.SGD","LU0320765059.SGD","TMO","FFOX","LU2357627491.SGD","BK4550","IE00B4R5TH58.HKD","SG9999014542.SGD","LU0130102774.USD","GB00BDT5M118.USD","LU2264538146.SGD","LU0889565916.HKD","LU0158827948.USD","BK4139","ELIS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677005596","title":"Genenta Science receives Nasdaq minimum bid price deficiency notice","url":"https://stock-news.laohu8.com/highlight/detail?id=2677005596","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677005596?lang=en_us&edition=fundamental","pubTime":"2026-10-22 04:55","pubTimestamp":1792616128,"startTime":"0","endTime":"0","summary":"Genenta Science (GNTA) announced that on October 16 it received a notification letter from the Listing Qualifications Department of Nasdaq indicati...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/genenta-science-receives-nasdaq-minimum-bid-price-deficiency-notice-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/genenta-science-receives-nasdaq-minimum-bid-price-deficiency-notice-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GNTA","BK4139","NQmain","LCLG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677660708","title":"ADAR1 Capital Management Reports Acquisition of $1.46 Million in Tenax Therapeutics Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2677660708","media":"Reuters","labels":["insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677660708?lang=en_us&edition=fundamental","pubTime":"2026-10-22 04:50","pubTimestamp":1792615840,"startTime":"0","endTime":"0","summary":"ADAR1 Capital Management Reports Acquisition of $1.46 Million in Tenax Therapeutics Common SharesADAR1 Capital Management reported purchases of 922,849 Tenax Therapeutics common shares, increasing rep","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261021:nNDLb1LY1y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"ADAR1 Capital Management Reports Acquisition of $1.46 Million in Tenax Therapeutics Common Shares","news_tag":"insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","TENX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677414607","title":"Arcus Biosciences Drops After Starting Stock Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2677414607","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677414607?lang=en_us&edition=fundamental","pubTime":"2026-10-22 04:41","pubTimestamp":1792615297,"startTime":"0","endTime":"0","summary":"BUZZ-Arcus Biosciences drops after starting stock offering** Shares of Arcus BiosciencesRCUS.Ndown 4.4% at $18.26 in extended trading after equity offering news** Cancer and immune diseases-focused bi","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261021:nL6N4671C8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RCUS","BK4139","BK4127","BK4559","JEF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677607411","title":"3 ‘Strong Buy’ High-Risk Stocks with Double-Gain Potential","url":"https://stock-news.laohu8.com/highlight/detail?id=2677607411","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677607411?lang=en_us&edition=fundamental","pubTime":"2026-10-22 04:39","pubTimestamp":1792615173,"startTime":"0","endTime":"0","summary":"Praxis Precision Medicines ($PRAX), Quantinuum ($QNT), and Galaxy Digital ($GLXY) are three high-risk, high-reward stocks analysts recommend watchi...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/3-strong-buy-high-risk-stocks-with-double-gain-potential?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/3-strong-buy-high-risk-stocks-with-double-gain-potential?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE0002141913.USD","IE00B4R5TH58.HKD","IE00BFTCPJ56.SGD","PRAX","IE00BJJMRZ35.SGD","IE0009355771.USD","LU0109394709.USD","BK4139","LU0889565916.HKD","IBRN","IE00BJT1NW94.SGD","LU0320765992.SGD","IE00B2B36J28.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677607957","title":"United Therapeutics Chairperson and CEO Martine A. Rothblatt Reports Disposal of $5.26 Million in Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2677607957","media":"Reuters","labels":["insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677607957?lang=en_us&edition=fundamental","pubTime":"2026-10-22 04:37","pubTimestamp":1792615033,"startTime":"0","endTime":"0","summary":"United Therapeutics Chairperson and CEO Martine A. Rothblatt Reports Disposal of $5.26 Million in Common SharesUnited Therapeutics Chairperson and CEO Martine A. Rothblatt sold 9,500 common shares on ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261021:nNDL90fyk1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"United Therapeutics Chairperson and CEO Martine A. Rothblatt Reports Disposal of $5.26 Million in Common Shares","news_tag":"insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["UTHR","BK4532","LU1571399168.USD","LU1699723380.USD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677076486","title":"Forum Markets Forecasts 2027 Consolidated Revenue of $125 Million-$175 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2677076486","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677076486?lang=en_us&edition=fundamental","pubTime":"2026-10-22 04:36","pubTimestamp":1792614966,"startTime":"0","endTime":"0","summary":"Forum Markets Forecasts 2027 Consolidated Revenue of $125 Million-$175 MillionForum Markets forecasts 2027 consolidated revenue of $125 million-$175 million, primarily supported by its initial AI comp","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261021:nNDL1vrf7z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FRMM","BK4023","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677607649","title":"Alaunos Therapeutics Says it Regains Compliance with NASDAQ Stockholders' Equity Requirement","url":"https://stock-news.laohu8.com/highlight/detail?id=2677607649","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677607649?lang=en_us&edition=fundamental","pubTime":"2026-10-22 04:35","pubTimestamp":1792614928,"startTime":"0","endTime":"0","summary":"Alaunos Therapeutics Says It Regains Compliance With Nasdaq Stockholders' Equity RequirementAlaunos Therapeutics believes it has regained compliance with Nasdaq’s $2.5 million minimum stockholders’ eq","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261021:nNDL1XMglm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TCRT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"compareEarnings":[{"period":"1week","weight":0.0045},{"period":"1month","weight":-0.0005},{"period":"3month","weight":0.0473},{"period":"6month","weight":0.0829},{"period":"1year","weight":0.1516},{"period":"ytd","weight":0.1337}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"name":"BK4139","nameEN":"BK4139"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.52.0","shortVersion":"4.52.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Biotechnology(BK4139),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Biotechnology(BK4139) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Biotechnology,BK4139,Biotechnology股票,Biotechnology股票老虎,Biotechnology股票老虎国际,Biotechnology行情,Biotechnology股票行情,Biotechnology股价,Biotechnology股市,Biotechnology股票价格,Biotechnology股票交易,Biotechnology股票购买,Biotechnology股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Biotechnology(BK4139),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Biotechnology(BK4139) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction